Moody National Bank Trust Division lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 11.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 17,505 shares of the healthcare conglomerate’s stock after selling 2,305 shares during the quarter. UnitedHealth Group comprises about 0.3% of Moody National Bank Trust Division’s holdings, making the stock its 14th largest holding. Moody National Bank Trust Division’s holdings in UnitedHealth Group were worth $8,927,000 as of its most recent filing with the SEC.
Other large investors also recently bought and sold shares of the company. Outfitter Financial LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Blue Bell Private Wealth Management LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth $29,000. Advocacy Wealth Management Services LLC increased its stake in UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. increased its stake in UnitedHealth Group by 100.0% during the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 30 shares during the last quarter. Finally, Tortoise Investment Management LLC increased its stake in UnitedHealth Group by 54.8% during the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 23 shares during the last quarter. 87.48% of the stock is owned by hedge funds and other institutional investors.
UNH has been the subject of several research analyst reports. Loop Capital initiated coverage on UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target for the company. BMO Capital Markets raised their price target on UnitedHealth Group from $510.00 to $600.00 and gave the stock a “market perform” rating in a research report on Tuesday, April 19th. Truist Financial raised their price target on UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Oppenheimer lifted their target price on UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a report on Monday, April 18th. Finally, Wells Fargo & Company decreased their target price on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating for the company in a report on Wednesday, May 25th. Three research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $555.73.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, topping analysts’ consensus estimates of $5.40 by $0.09. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The business had revenue of $80.15 billion for the quarter, compared to analysts’ expectations of $78.77 billion. During the same quarter in the previous year, the firm earned $5.31 earnings per share. The business’s revenue was up 14.2% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 21.75 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be given a $1.65 dividend. This represents a $6.60 annualized dividend and a yield of 1.35%. The ex-dividend date of this dividend is Thursday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s payout ratio is 36.12%.
In related news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction dated Monday, May 16th. The stock was sold at an average price of $493.25, for a total value of $1,233,125.00. Following the transaction, the director now owns 1,220,000 shares in the company, valued at approximately $601,765,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Frederick William Mcnabb III purchased 89 shares of the company’s stock in a transaction that occurred on Thursday, May 26th. The stock was bought at an average price of $504.32 per share, for a total transaction of $44,884.48. Following the transaction, the director now directly owns 11,259 shares in the company, valued at $5,678,138.88. The disclosure for this purchase can be found here. Insiders own 0.40% of the company’s stock.
About UnitedHealth Group (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.